Nwizu CR, Nnadi CO, Igboasoiyi AC. Structure-Based Virtual Screening Identifies Ritobegron and Resveratrol as Dual Inhibitors of NMDA and PTP-1B for Alzheimer’s Disease Therapy. TJPPS [Internet]. 2026 Apr. 11 [cited 2026 Apr. 14];5(2):468-74. Available from: https://tjpps.org/index.php/home/article/view/256